Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 18, 2024 |
referred to health |
Assembly Bill A8836
2023-2024 Legislative Session
Sponsored By
BERGER
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2023-A8836 (ACTIVE) - Details
2023-A8836 (ACTIVE) - Summary
Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of the ten prescription drugs on which the state expends the most money and which have had certain costs increased by fifty percent or more over the past five years or by ten percent or more during the previous calendar year.
2023-A8836 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8836 I N A S S E M B L Y January 18, 2024 ___________ Introduced by M. of A. BERGER -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to requiring the commissioner of health to include in annual reports information regarding the cost and increase in cost of certain prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 1 of section 277 of the public health law, as amended by section 18 of part A of chapter 56 of the laws of 2013, is amended to read as follows: 1. The commissioner, in consultation with the drug utilization review board, shall undertake periodic reviews, at least annually, of the preferred drug program which shall include consideration of: (a) the volume of prior authorizations being handled, including data on the number and characteristics of prior authorization requests for particular prescription drugs; (b) the quality of the program's responsiveness, including the quality of the administrator's responsiveness; (c) complaints received from patients and providers; (d) (I) A LIST OF THE TEN PRESCRIPTION DRUGS ON WHICH THE STATE EXPENDS THE MOST MONEY AND FOR WHICH THE WHOLESALE ACQUISITION COST HAS INCREASED BY FIFTY PERCENT OR MORE OVER THE PAST FIVE YEARS OR BY TEN PERCENT OR MORE DURING THE PREVIOUS CALENDAR YEAR. THE COMMISSIONER SHALL: INCLUDE THE PERCENTAGE OF THE WHOLESALE ACQUISITION COST INCREASE FOR EACH DRUG ON THE LIST; RANK THE DRUGS ON THE LIST FROM THOSE WITH THE LARGEST INCREASE IN WHOLESALE ACQUISITION COST TO THOSE WITH THE SMALLEST INCREASE; INDICATE WHETHER EACH DRUG WAS INCLUDED ON THE LIST BASED ON ITS COST INCREASE OVER THE PAST FIVE YEARS OR DURING THE PREVI- OUS CALENDAR YEAR, OR BOTH; AND PROVIDE THE STATE'S TOTAL EXPENDITURE FOR EACH DRUG ON THE LIST DURING THE MOST RECENT CALENDAR YEAR; AND (II) A LIST OF THE TEN PRESCRIPTION DRUGS ON WHICH THE STATE EXPENDS THE MOST MONEY AND FOR WHICH THE COST TO THE STATE, NET OF REBATES AND OTHER PRICE CONCESSIONS, HAS INCREASED BY FIFTY PERCENT OR MORE OVER THE PAST FIVE YEARS OR BY TEN PERCENT OR MORE DURING THE PREVIOUS CALENDAR EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.